PHIO · Company research
Phio Pharmaceuticals Corp. Common Stock (PHIO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. PHIO Stock Forecast & Price Target - Yahoo! Finance Canada | Phio Pharmaceuticals Corp. PHIO Stock Forecast & Price Target Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 13, 2026 | neutral | 0 | 0.6 |
| A cancer drug's first production-scale batch is complete; a clinical study is planned for early 2027. - Stock Titan | A cancer drug's first production-scale batch is complete; a clinical study is planned for early 2027. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Phio Pharmaceuticals Corp. PHIO Stock Forecast & Price Target - Yahoo! Finance Canada | Phio Pharmaceuticals Corp. PHIO Stock Forecast & Price Target Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 8, 2026 | neutral | 0 | 0.6 |
| A cancer approach designed to help immune cells fight tumors is the focus of Phio's presentation. - Stock Titan | A cancer approach designed to help immune cells fight tumors is the focus of Phio's presentation. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| Phio Pharmaceuticals Corp. PHIO Stock Forecast & Price Target - Yahoo Finance | Phio Pharmaceuticals Corp. PHIO Stock Forecast & Price Target Yahoo Finance | View source ↗ | Yahoo Finance | Oct 5, 2026 | neutral | 0 | 0.6 |
| A planned Florida talk will cover Phio's skin cancer program - Stock Titan | A planned Florida talk will cover Phio's skin cancer program Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| PHIO Stock Slips to $0.98 as Phio Pharmaceuticals Holds Near Key Support - Cash Secured Put - https://www.siam.in/ | PHIO Stock Slips to $0.98 as Phio Pharmaceuticals Holds Near Key Support - Cash Secured Put https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 5, 2026 | neutral | 0 | 0.6 |
| A director buys 10,000 shares of Phio Pharmaceuticals (PHIO) at $1.03 and $1.04 per share. - Stock Titan | A director buys 10,000 shares of Phio Pharmaceuticals (PHIO) at $1.03 and $1.04 per share. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| A director’s grant at Phio Pharmaceuticals (PHIO) covers 17,000 shares that vest in a year. - Stock Titan | A director’s grant at Phio Pharmaceuticals (PHIO) covers 17,000 shares that vest in a year. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| A CEO's stock award will vest after a year at Phio Pharmaceuticals (PHIO). - Stock Titan | A CEO's stock award will vest after a year at Phio Pharmaceuticals (PHIO). Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Phio Pharmaceuticals Director Ronald Todd Plott Granted 17,000 Restricted Stock Units - Kalkine Media | Phio Pharmaceuticals Director Ronald Todd Plott Granted 17,000 Restricted Stock Units Kalkine Media | View source ↗ | Kalkine Media | Sep 29, 2026 | neutral | 0 | 0.6 |
| Phio Pharmaceuticals CFO Lisa Cabott Carson Granted 108,000 Restricted Stock Units - Kalkine Media | Phio Pharmaceuticals CFO Lisa Cabott Carson Granted 108,000 Restricted Stock Units Kalkine Media | View source ↗ | Kalkine Media | Sep 29, 2026 | neutral | 0 | 0.6 |
| At $1.0127 a share, a Phio Pharmaceuticals (PHIO) director bought 6,500 shares. - Stock Titan | At $1.0127 a share, a Phio Pharmaceuticals (PHIO) director bought 6,500 shares. Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| A potential skin cancer treatment completed a clinical study. Phio will discuss next steps Sept. 30. - Stock Titan | A potential skin cancer treatment completed a clinical study. Phio will discuss next steps Sept. 30. Stock Titan | View source ↗ | Stock Titan | Sep 23, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $PHIO Buys 15,000 Shares | PHIO Stock News - Quiver Quantitative | Insider Purchase: Director at $PHIO Buys 15,000 Shares | PHIO Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 20, 2026 | neutral | 0 | 0.6 |
| Price to earnings forward of Phio Pharmaceuticals Corp. – NASDAQ:PHIO - TradingView | Price to earnings forward of Phio Pharmaceuticals Corp. – NASDAQ:PHIO TradingView | View source ↗ | TradingView | Aug 19, 2026 | neutral | 0 | 0.6 |
| $PHIO stock is down 8% today. Here's what we see in our data. - Quiver Quantitative | $PHIO stock is down 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 15, 2026 | neutral | 0 | 0.6 |
| PHIO Forecast — Price Target — Prediction for 2027 - TradingView | PHIO Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.